6.
Al Hamed R, Bazarbachi A, Mohty M
. Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities. Bone Marrow Transplant. 2019; 55(1):25-39.
DOI: 10.1038/s41409-019-0548-7.
View
7.
Qi S, Li Y, Specht L, Oguchi M, Tsang R, Ng A
. Modern Radiation Therapy for Extranodal Nasal-Type NK/T-cell Lymphoma: Risk-Adapted Therapy, Target Volume, and Dose Guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2021; 110(4):1064-1081.
DOI: 10.1016/j.ijrobp.2021.02.011.
View
8.
Stokkermans-Dubois J, Jouary T, Vergier B, Delaunay M, Taieb A
. A case of primary cutaneous nasal type NK/T-cell lymphoma and review of the literature. Dermatology. 2006; 213(4):345-9.
DOI: 10.1159/000096201.
View
9.
Chai C, White W, Shea C, Prieto V
. Epstein Barr virus-associated lymphoproliferative-disorders primarily involving the skin. J Cutan Pathol. 1999; 26(5):242-7.
DOI: 10.1111/j.1600-0560.1999.tb01837.x.
View
10.
Zimmermann H, Nitsche M, Pott C, Reinke P, Babel N, Hermann R
. Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the.... Ann Hematol. 2021; 100(8):2043-2050.
DOI: 10.1007/s00277-021-04548-2.
View
11.
Dierickx D, Tousseyn T, Sagaert X, Fieuws S, Wlodarska I, Morscio J
. Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors. Leuk Lymphoma. 2013; 54(11):2433-40.
DOI: 10.3109/10428194.2013.780655.
View
12.
Al-Mansour Z, Nelson B, Evens A
. Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep. 2013; 8(3):173-83.
PMC: 4831913.
DOI: 10.1007/s11899-013-0162-5.
View
13.
. [Chinese consensus on the diagnosis and management of Epstein-Barr virus-related post-transplant lymphoproliferative disorders after hematopoietic stem cell transplantation (2022)]. Zhonghua Xue Ye Xue Za Zhi. 2023; 43(9):716-725.
PMC: 9613495.
DOI: 10.3760/cma.j.issn.0253-2727.2022.09.002.
View
14.
Kempf C, Tinguely M, Rushing E
. Posttransplant lymphoproliferative disorder of the central nervous system. Pathobiology. 2013; 80(6):310-8.
DOI: 10.1159/000347225.
View
15.
Landgren O, Gilbert E, Rizzo J, Socie G, Banks P, Sobocinski K
. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood. 2009; 113(20):4992-5001.
PMC: 2686146.
DOI: 10.1182/blood-2008-09-178046.
View
16.
Wang H, Fu B, Gale R, Liang Y
. NK-/T-cell lymphomas. Leukemia. 2021; 35(9):2460-2468.
PMC: 8410593.
DOI: 10.1038/s41375-021-01313-2.
View
17.
Herreman A, Dierickx D, Morscio J, Camps J, Bittoun E, Verhoef G
. Clinicopathological characteristics of posttransplant lymphoproliferative disorders of T-cell origin: single-center series of nine cases and meta-analysis of 147 reported cases. Leuk Lymphoma. 2013; 54(10):2190-9.
DOI: 10.3109/10428194.2013.775436.
View
18.
Berti E, Recalcati S, Girgenti V, Fanoni D, Venegoni L, Vezzoli P
. Cutaneous extranodal NK/T-cell lymphoma: a clinicopathologic study of 5 patients with array-based comparative genomic hybridization. Blood. 2010; 116(2):165-70.
DOI: 10.1182/blood-2009-11-252957.
View
19.
Dharnidharka V, Webster A, Martinez O, Preiksaitis J, Leblond V, Choquet S
. Post-transplant lymphoproliferative disorders. Nat Rev Dis Primers. 2016; 2:15088.
DOI: 10.1038/nrdp.2015.88.
View
20.
Molina-Ruiz A, Pulpillo A, Lasanta B, Zulueta T, Andrades R, Requena L
. A rare case of primary cutaneous plasmacytoma-like lymphoproliferative disorder following renal transplantation. J Cutan Pathol. 2012; 39(7):685-9.
DOI: 10.1111/j.1600-0560.2012.01919.x.
View